15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Alignment Healthcare LLC, 5 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $16.00 to $30.00, a moderate spread. The average target of $23.00 sits 23% above the current $18.67. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 31% this year and 25% next, consensus EPS building from about $0.14 next quarter toward $0.72 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy571%
Hold229%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Alignment Healthcare LLC.
As of Jul, 5 of 7 firms rate ALHC a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ALHC EPS & revenue forecast
EPS · NEXT QUARTER
$0.14
Range $0.11 – $0.16 · 4 analysts · +38% YoY
Next period, 4 analysts expect Alignment Healthcare LLC to earn $0.14 a share (range $0.11 – $0.16), versus $0.10 a year earlier. Full-year consensus is $0.47, growing to $0.72 the year after.
REVENUE · NEXT QUARTER
$1.3B
Range $1.3B – $1.3B · 4 analysts · +32% YoY
Revenue is expected to reach $1.3B (range $1.3B – $1.3B), +32.0% year-over-year. Full-year consensus is $5.2B, rising to $6.5B next year.
Top analysts covering Alignment Healthcare LLC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ALHC.
#1
Andrew Mok
Barclays
Hold
$16.00-14.3% to target
Coverage
—
+ Follow
#2
Jessica Tassan
Piper Sandler
Buy
$30.00+60.7% to target
Coverage
—
+ Follow
#3
JS
John Stansel
JP Morgan
Buy
$26.00+39.3% to target
Coverage
—
+ Follow
#4
Kevin Caliendo
UBS
Hold
$21.00+12.5% to target
Coverage
—
+ Follow
#5
AM
Andrew Mok CFA
Barclays
Hold
$16.00-14.3% to target
Coverage
—
+ Follow
ALHC stock forecast FAQ
What is ALHC's average 12-month price target?+
The 7 analysts with a live target average $23.00 for Alignment Healthcare LLC over the next 12 months, ranging from a $30.00 high to a $16.00 low.
Is ALHC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 5 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ALHC?+
The Street-high target is $30.00 (Piper Sandler), and the Street-low is $16.00 (Barclays). The average of all 7 active targets is $23.00.
How many Wall Street analysts cover ALHC?+
7 analysts have an active rating on Alignment Healthcare LLC, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering ALHC?+
Among analysts who currently cover ALHC, Andrew Mok of Barclays has the strongest overall Quantellect track record. Their current call is Hold with a $16.00 target.
What is Alignment Healthcare LLC's projected EPS for next quarter?+
The consensus estimate is $0.14 per share (range $0.11 – $0.16) across 4 analysts. Full-year EPS is projected at $0.47, rising to $0.72 the following year.
How much revenue is Alignment Healthcare LLC expected to report next quarter?+
Consensus revenue is $1.3B (range $1.3B – $1.3B). Full-year revenue is projected at $5.2B, growing to $6.5B next year.
Have analysts been upgrading or downgrading ALHC lately?+
As of Jul, 5 of 7 firms rate ALHC a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ALHC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
